Cargando…
Impact of Maleimide Disubstitution on Chemical and Biological Characteristics of HER2 Antibody–Drug Conjugates
[Image: see text] Antibody–drug conjugates (ADCs) are the spearhead of targeted therapies. According to the technology used, the conjugation of a cytotoxic drug to an antibody can produce suboptimal heterogeneous species, impacting the overall efficacy. Herein, we describe the synthesis of HER2-targ...
Autores principales: | Feuillâtre, Ofelia, Gély, Camille, Huvelle, Steve, Baltus, Christine B., Juen, Ludovic, Joubert, Nicolas, Desgranges, Audrey, Viaud-Massuard, Marie-Claude, Martin, Camille |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990629/ https://www.ncbi.nlm.nih.gov/pubmed/32010829 http://dx.doi.org/10.1021/acsomega.9b03510 |
Ejemplares similares
-
Antibody–Drug Conjugates as an Emerging Therapy in Oncodermatology
por: Esnault, Clara, et al.
Publicado: (2022) -
Antibody-drug conjugates: Design and development for therapy and imaging in and beyond cancer, LabEx MAbImprove industrial workshop, July 27–28, 2017, Tours, France
por: Martin, Camille, et al.
Publicado: (2018) -
In Vitro Characterization and Stability Profiles of Antibody–Fluorophore Conjugates Derived from Interchain Cysteine Cross-Linking or Lysine Bioconjugation
por: Martin, Camille, et al.
Publicado: (2019) -
Improving the Stability of Maleimide–Thiol Conjugation for Drug Targeting
por: Lahnsteiner, Marianne, et al.
Publicado: (2020) -
Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers
por: Brachet-Botineau, Marie, et al.
Publicado: (2020)